Industry Bulletins | November 9, 2022
Aptar Pharma Expands Digital Health Portfolio With New Consumer-Focused Disease Management Platform
Aptar Pharma launched a new disease management platform to support consumer treatment journeys from prevention and diagnosis to disease management using long-term therapies for chronic health conditions. The platform is a complete, end-to-end solution across multiple therapeutic areas. It expands Aptar Pharma’s portfolio of commercial digital health solutions for its life science industrial partners, payers, and provider organizations.
Care teams using the disease management platform can access real-time remote data monitoring to track the consumer’s adherence to their treatment plan. Consumers using the platform will be able to access support for each stage of . . .